PONTI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.303
EU - Europa 9.697
AS - Asia 9.021
SA - Sud America 1.432
Continente sconosciuto - Info sul continente non disponibili 427
AF - Africa 201
OC - Oceania 24
Totale 48.105
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.534
GB - Regno Unito 3.279
SG - Singapore 2.886
IT - Italia 2.381
CN - Cina 2.156
HK - Hong Kong 1.108
BR - Brasile 1.090
VN - Vietnam 953
SE - Svezia 908
DE - Germania 772
FI - Finlandia 510
BD - Bangladesh 499
UA - Ucraina 485
CA - Canada 467
RU - Federazione Russa 368
FR - Francia 348
TR - Turchia 348
IN - India 214
KR - Corea 193
BG - Bulgaria 170
MX - Messico 148
ID - Indonesia 130
AR - Argentina 111
IQ - Iraq 91
NL - Olanda 89
JP - Giappone 72
IE - Irlanda 60
ZA - Sudafrica 59
EC - Ecuador 54
PL - Polonia 51
ES - Italia 49
CO - Colombia 48
PK - Pakistan 45
AE - Emirati Arabi Uniti 41
MY - Malesia 37
VE - Venezuela 34
CL - Cile 32
CR - Costa Rica 30
MA - Marocco 29
BE - Belgio 28
LT - Lituania 25
PH - Filippine 25
SA - Arabia Saudita 25
JM - Giamaica 24
JO - Giordania 24
EG - Egitto 23
KE - Kenya 23
UZ - Uzbekistan 23
AT - Austria 22
PY - Paraguay 22
AU - Australia 21
TH - Thailandia 21
CH - Svizzera 20
PE - Perù 19
RO - Romania 19
NP - Nepal 17
CZ - Repubblica Ceca 15
IL - Israele 15
AZ - Azerbaigian 14
GT - Guatemala 14
TN - Tunisia 14
DZ - Algeria 13
PT - Portogallo 13
DO - Repubblica Dominicana 12
HU - Ungheria 12
NI - Nicaragua 12
IR - Iran 11
KZ - Kazakistan 11
PA - Panama 11
TT - Trinidad e Tobago 11
BO - Bolivia 10
EU - Europa 10
HN - Honduras 10
LU - Lussemburgo 10
PR - Porto Rico 10
DK - Danimarca 9
NO - Norvegia 9
PS - Palestinian Territory 9
UY - Uruguay 9
NG - Nigeria 8
BH - Bahrain 7
LB - Libano 7
RS - Serbia 7
SV - El Salvador 6
AL - Albania 5
EE - Estonia 5
ET - Etiopia 5
KG - Kirghizistan 5
MD - Moldavia 5
OM - Oman 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
AM - Armenia 4
GE - Georgia 4
SC - Seychelles 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
Totale 47.627
Salva come PNG Salva come JPEG
Città #
Ashburn 3.132
Fairfield 2.539
Southend 2.473
Santa Clara 1.970
Singapore 1.683
Woodbridge 1.580
Houston 1.185
Hong Kong 1.093
Seattle 993
Chandler 923
San Jose 922
Wilmington 851
Jacksonville 837
Cambridge 815
Dearborn 786
Council Bluffs 692
Ann Arbor 661
Chicago 617
Nyköping 543
Los Angeles 508
Beijing 503
Hefei 472
London 425
Helsinki 353
Ho Chi Minh City 285
Modena 284
Salt Lake City 249
New York 238
The Dalles 231
Hanoi 228
Milan 219
San Diego 209
Princeton 204
Ottawa 195
Izmir 188
Seoul 181
Sofia 167
Rome 164
Eugene 155
Buffalo 142
Shanghai 139
Tampa 128
Dallas 127
Lauterbourg 127
São Paulo 127
Boardman 118
Elk Grove Village 117
Columbus 114
Montreal 99
Moscow 97
Orem 94
Jakarta 88
Bremen 81
Phoenix 76
Frankfurt am Main 75
Munich 75
Sterling 72
Lancaster 64
Toronto 59
Atlanta 58
Dublin 57
Redwood City 55
Grafing 51
Bologna 49
Tokyo 48
Da Nang 47
Dong Ket 44
Haiphong 43
Turin 42
Denver 41
Des Moines 40
Miami 40
Warsaw 39
Brooklyn 38
Detroit 38
Guangzhou 38
Naples 38
North Bergen 36
Rio de Janeiro 36
Norwalk 35
Philadelphia 34
Fremont 33
Chennai 32
Mexico City 32
Belo Horizonte 30
Washington 29
Palermo 28
Baghdad 27
Boston 27
Dulles 27
Pittsburgh 26
New Delhi 25
Miano 24
Redondo Beach 24
Saint Augustine 24
San Francisco 24
San José 24
Dongguan 23
Kunming 23
Nanjing 23
Totale 33.224
Salva come PNG Salva come JPEG
Nome #
Mutazioni somatiche di BRAF in pazienti affetti da melanoma maligno metastatico ed efficacia clinica degli approcci terapeutici a bersaglio molecolare con inibitori di BRAF 641
Wall paintings facies and their possible genetic correlates in the ancient Pompeii: A bio-anthropologic message from the past? 634
Neoplasie maligne e benigne associate al melanoma multiplo: coinvolgimento di MITF, PTEN and CDKN2A nella cancerogenesi melanocitaria multipla. 624
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 472
The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patients 470
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 469
Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA) 465
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 462
Reticular grey-blue areas of regression as a dermoscopic marker of melanoma in situ. 457
Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome 457
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 452
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-asociated polyposis pedigrees 444
Brooke-Spiegler syndrome: Report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes 437
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLD mutation in Brenner tumor 433
"Collision" metastasis from unknown primary squamous cell carcinoma and papillary microcarcinoma of thyroid presenting as lateral cervical cystic mass 432
Caso di Neurofibromatosi diagnosticata a 71 anni 424
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or Keratoacanthomas 419
Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients 414
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 413
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 410
A novel CYLD germline mutation in Brooke-Spiegler syndrome. 405
Seminal Cell-Free DNA Assessment as a Novel Prostate Cancer Biomarker 405
Multiphoton laser tomography and fluorescence lifetime imaging of melanoma: morphologic features and quantitative data for sensitive and specific non-invasive diagnostics. 400
Aetiology of colorectal cancer and relevance of monogenic inheritance. 395
Congenital Glioblastoma multiforme and eruptive disseminated Spitz nevi 393
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 388
Ameloblastoma: A neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome 386
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 386
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome. 384
Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer 383
Diagnostic and pathogenetic role of café-au-lait macules in nevoid basal cell carcinoma syndrome 383
Hereditary trichilemmal cysts: a proposal for the assessment of diagnostic clinical criteria 382
M09Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 381
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 377
Variegated Dermoscopy of in situ Melanoma. 376
BRAF ,NRASandC-KITAdvanced Melanoma: Clinico-pathological Features, Targeted-Therapy Strategies and Survival 372
Giant elephantiasis neuromatosa in the setting of neurofibromatosis type 1: A case report 372
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis 368
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 363
Hypomelanosis of Ito with a trisomy 2 mosaicism: a case report 361
Biomarkers associated with COVID-19 disease progression 359
Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy 354
Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology 354
High Magnification Digital Dermoscopy of Basal Cell Carcinoma: A Single-centre Study on 400 cases. 352
PTCH1 germline mutations and the basaloid follicular hamartoma values in the tumor spectrum of basal cell carcinoma syndrome (NBCCS) 351
Dermoscopy of small melanomas: just a miniaturized dermoscopy? 350
Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. 350
The impact of histopathologic diagnosis on the proper management of testis neoplasms. 348
Unicystic ameloblastoma associated with the novel K729M PTCH1 mutation in a patient with nevoid basal cell carcinoma (Gorlin) syndrome. 348
Skeletal and cranio-facial signs in Gorlin syndrome from ancient Egypt to the modern age: Sphenoid asymmetry in a patient with a novel PTCH1 mutation 348
Grey-blue regression in melanoma in situ-evaluation on 111 cases. 347
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 347
BRAFp.V600E, p.V600K, and p.V600R Mutations in Malignant Melanoma: Do They Also Differ in Immunohistochemical Assessment and Clinical Features? 345
Confocal microscopy characterization of BRAFV600E mutated melanomas 345
Fluorescence in-situ hybridization and dermoscopy in the assessment of controversial melanocytic tumors. 343
Muir-Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients 343
Skeletal stigmata as keys to access to the composite and ancient Gorlin-Goltz syndrome history: The Egypt, Pompeii and Herculaneum lessons 341
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 339
Microsatellite instability, immunohistochemistry and germline mismatch repair gene mutations for the diagnosis of Muir-Torre syndrome in immunosuppressed patients 337
Microsatellite instability and colorectal cancer prognosis. 335
NF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies 335
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. 333
Is confocal microscopy a valuable tool in diagnosing nodular lesions? A study on 140 cases. 332
Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanomas 326
Biological characterization of mucinous carcinoma of the colon and rectum 324
Cancer-associated genodermatoses: Skin neoplasms as clues to hereditary tumor syndromes. 319
Oral mucosal stigmata in hereditary-cancer syndromes: From germline mutations to distinctive clinical phenotypes and tailored therapies 315
Desmoplastic melanoma: a challenge for the oncologist 313
Mismatch Repair Gene Deficiency and Genetic Anticipation in Lynch Syndrome 312
Relationship between histological and computer based assessment of melanoma diameter and thickness in head & neck vs. trunk melanoma. 311
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 308
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 307
Seminal cell free DNA concentration levels discriminate between prostate cancer and benign prostatic hyperplasia 307
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 303
Fibroepithelioma of Pinkus: Solitary tumor or sign of a complex gastrointestinal syndrome 302
Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma 300
Seminal cell-free DNA assessment as a novel prostate cancer biomarker 299
Diagnosis of BCC by multiphoton laser tomography. 298
Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. 297
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 295
Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer 295
The dermoscopic variability of pigment network in melanoma in situ. 293
Role of microsatellite instability, immunohistochemistry and Mismatch Repair germline aberrations in immunosuppressed transplant patients: a phenocopy dilemma in Muir-Torre Syndrome. 292
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 292
Can noninvasive imaging tools potentially predict the risk of ulceration in invasive melanomas showing blue and black colors? 291
Are the neck malignant melanomas different from the ones affecting the head? Clinicopathologic, dermoscopic and prognostic findings 290
Muir-Torre Syndrome and founder Mismatch Repair genes mutations: A long gone historical genetic challenge 283
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 282
Multiphoton laser tomography and fluorescence lifetime imaging of basal cell carcinoma: morphologic features for non-invasive diagnostics 275
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 274
The somatic affairs of BRAF: tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutations. 271
Seminal cell-free DNA molecular profile as a novel diagnostic and prognostic prostate cancer biomarkers 270
High-resolution imaging of basal cell carcinoma: a comparison between multiphoton microscopy with fluorescence lifetime imaging and reflectance confocal microscopy. 270
Distinctive clinical and dermoscopic features of BRAFp.V600K mutated melanomas. 266
Dabrafenib-trametinib combination in 'field-practice': An Italian experience 262
Proteomic Analysis of PTCH1+/- Fibroblast Lysate and Conditioned Culture Media Isolated from the Skin of Healthy Subjects and Nevoid Basal Cell Carcinoma Syndrome Patients. 261
Stem cell properties in cell cultures from different stage of melanoma progression. 260
Caratterizzazione immunoistochimica e biomolecolare del carcinoma colorettale giovanile 260
Erratum: Molecular targeted approaches for advanced BRAF V600, N-RAS, c-KIT, and GNAQ melanoma (Disease Markers) 257
High resolution diagnosis of common nevi by multiphoton laser tomography and fluorescence lifetime imaging. 255
Totale 35.760
Salva come PNG Salva come JPEG
Categoria #
all - tutte 178.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 178.829
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.287 0 0 0 182 73 176 175 184 360 238 553 346
2022/20232.776 357 345 210 236 329 383 59 255 316 51 133 102
2023/20241.862 86 90 129 174 383 193 193 216 53 48 100 197
2024/20256.728 193 63 92 405 1.297 1.049 455 429 707 365 677 996
2025/202613.190 637 376 887 1.800 2.756 810 1.377 615 1.183 1.035 1.017 697
2026/20274.134 559 887 1.099 1.589 0 0 0 0 0 0 0 0
Totale 48.105